首页|miR-17-5p、IL-6及MCP-1联合检测对卵巢子宫内膜异位症患者术后复发的预测价值

miR-17-5p、IL-6及MCP-1联合检测对卵巢子宫内膜异位症患者术后复发的预测价值

扫码查看
目的 分析研究血清微小RNA-17-5p(miR-17-5p)、白细胞介素-6(IL-6)及单核细胞趋化蛋白1(MCP-1)联合检测对卵巢子宫内膜异位症(OEM)患者术后复发的预测价值.方法 选取郑州大学第三附属医院2019年1月至2022年12月收治的OEM患者作为研究对象,将其命名为OEM组(n=100),另选同期在本院进行体检的健康女性为对照组(n=60).比较两组血清miR-17-5p、IL-6及MCP-1水平;OEM组患者在入院后均进行手术与药物对症治疗,在治疗结束后对患者随访12个月.以多因素Logistic回归分析OEM患者术后复发的影响因素,并绘制ROC曲线分析血清miR-17-5p、IL-6、MCP-1水平对OEM患者术后复发的预测价值.结果 OEM组的血清miR-17-5p水平低于对照组,IL-6、MCP-1水平均高于对照组,差异有统计学意义(t=11.015、59.651、38.199,均P<0.05);多因素Logistic回归分析显示,囊肿直径>5 cm(OR=1.828)、ASRM分期为Ⅲ~Ⅳ期(OR=1.815)、血清miR-17-5p水平降低(OR=2.042)、IL-6水平升高(OR=2.136)及MCP-1水平升高(OR=1.966)均是OEM患者术后复发的独立危险因素(P<0.05);ROC曲线分析显示,血清miR-17-5p、IL-6、MCP-1水平及联合检测的曲线下面积(AUC)分别为0.816、0.781、0.745、0.933,联合检测优于单一检测(P<0.05).结论 miR-17-5p、IL-6及MCP-1联合检测对OEM患者术后复发具有一定预测价值.
Predictive value of combined detection of miR-17-5p,IL-6 and MCP-1 for postoperative recurrence in patients with ovarian endometriosis
Objective To analyze the predictive value of serum microRNA-17-5P(miR-17-5p), interleukin-6(IL-6)and monocyte chemoattractant protein-1(MCP-1)combined detection for postoperative re-currence in patients with ovarian endometriosis(OEM). Methods The OEM patients admitted to the Third Af-filiated Hospital of Zhengzhou University from January 2019 to December 2022 were retrospectively selected as the research suobjects and named categorized as the OEM group(n=100). and the hHealthy women who under-went physical examinations in our hospital during the same period were selected chosen as the control group(n=60). The serum levels of miR-17-5p,IL-6 and MCP-1 were compared between the two groups. All patients in the OEM group received surgery and symptomatic treatment after admission,and were followed up for 12 months after post-treatment. Univariate and multivariate lLogistic regression analyseis were used to analyze the influencing factors of postoperative recurrence in patients with OEM. and An ROC curve was drawn to analyze the predictive value of serum miR-17-5p,IL-6 and MCP-1 levels for postoperative recurrence in patients with OEM. Results The level of serum miR-17-5p in the OEM group was lower than that in the control group,and while the levels of IL-6 and MCP-1 in the OEM group were higher than those in the control group. Theseand the differences were statistically significant(t=11.015,59.651,38.199,all P<0.05). Multivariate lLogistic regres-sion analysis showed that The a cyst diameter>5 cm(OR=1.828),ASRM stage Ⅲ~Ⅳ(OR=1.815),decreased serum miR-17-5p level decreased (OR=2.042),increased IL-6 level increased (OR=2.136) and increased MCP-1 level increased (OR=1.966) were all independent risk factors of postoperative recurrence in OEM patients Risk factors(P<0.05). ROC curve analysis showed revealed that the levels of serum miR-17-5p,IL-6 and MCP-1 and the AUC of combined detection were 0.816,0.781,0.745 and 0.933,respectively. Combined detection was shown to be superior to single detection (P<0.05). Conclusion The combined detection of miR-17-5p,IL-6 and MCP-1 has a certain predictive value for postoperative recurrence in patients with OEM.

Ovarian endometriosisMicroRNA-17-5pInterleukin-6Monocyte chemoattractant protein 1Postoperative recurrence

刘冬霞、宋易坤、于航、薛闪辉、陈飞、奈嫚嫚、李蕾

展开 >

郑州大学第三附属医院盆底重建科,河南,郑州450052

卵巢子宫内膜异位症 微小RNA-17-5p 白细胞介素-6 单核细胞趋化蛋白1 术后复发

河南省医学科技攻关计划(联合共建)

号LHGJ20190362

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(3)
  • 14